379 related articles for article (PubMed ID: 32562550)
21. [Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?].
Nisole S; Saulnier A; Gatignol A
Virologie (Montrouge); 2020 Jun; 24(3):135-141. PubMed ID: 32648548
[No Abstract] [Full Text] [Related]
22. Potential strategies for combating COVID-19.
Shamim S; Khan M; Kharaba ZJ; Ijaz M; Murtaza G
Arch Virol; 2020 Nov; 165(11):2419-2438. PubMed ID: 32778950
[TBL] [Abstract][Full Text] [Related]
23. A Comprehensive Updated Review on SARS-CoV-2 and COVID-19.
Ren YR; Golding A; Sorbello A; Ji P; Chen J; Saluja B; Witzmann K; Arya V; Reynolds KS; Choi SY; Nikolov NP; Sahajwalla C
J Clin Pharmacol; 2020 Aug; 60(8):954-975. PubMed ID: 32469437
[TBL] [Abstract][Full Text] [Related]
24. The COVID-19 Cytokine Storm; What We Know So Far.
Ragab D; Salah Eldin H; Taeimah M; Khattab R; Salem R
Front Immunol; 2020; 11():1446. PubMed ID: 32612617
[TBL] [Abstract][Full Text] [Related]
25. Potential therapeutic targets and promising drugs for combating SARS-CoV-2.
Zhou H; Fang Y; Xu T; Ni WJ; Shen AZ; Meng XM
Br J Pharmacol; 2020 Jul; 177(14):3147-3161. PubMed ID: 32368792
[TBL] [Abstract][Full Text] [Related]
26. Experts Discuss COVID-19-Remdesivir, Vaccines, and More.
JAMA; 2020 Aug; 324(8):730-731. PubMed ID: 32777002
[No Abstract] [Full Text] [Related]
27. Critical COVID-19 disease, homeostasis, and the "surprise" of effective glucocorticoid therapy.
Chrousos GP; Meduri GU
Clin Immunol; 2020 Oct; 219():108550. PubMed ID: 32745524
[No Abstract] [Full Text] [Related]
28. Current development of COVID-19 diagnostics, vaccines and therapeutics.
Zhang N; Li C; Hu Y; Li K; Liang J; Wang L; Du L; Jiang S
Microbes Infect; 2020; 22(6-7):231-235. PubMed ID: 32387332
[TBL] [Abstract][Full Text] [Related]
29. An Urgent Need for "Common Cold Units" to Study COVID-19.
Halstead SB
Am J Trop Med Hyg; 2020 Jun; 102(6):1152-1153. PubMed ID: 32274988
[No Abstract] [Full Text] [Related]
30. COVID-19 will change MS care forever - No.
Preziosa P; Rocca MA; Filippi M
Mult Scler; 2020 Sep; 26(10):1149-1151. PubMed ID: 32567471
[No Abstract] [Full Text] [Related]
31. Emergence of novel coronavirus and progress toward treatment and vaccine.
Khan MM; Noor A; Madni A; Shafiq M
Rev Med Virol; 2020 Jul; 30(4):e2116. PubMed ID: 32495979
[TBL] [Abstract][Full Text] [Related]
32. Dapsone and doxycycline could be potential treatment modalities for COVID-19.
Farouk A; Salman S
Med Hypotheses; 2020 Jul; 140():109768. PubMed ID: 32339778
[No Abstract] [Full Text] [Related]
33. Audio Interview: What the U.S. Response to Covid-19 Looks Like Today.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 Nov; 383(19):e123. PubMed ID: 33211936
[No Abstract] [Full Text] [Related]
34. Role of Interleukin-6 in Lung Complications in Patients With COVID-19: Therapeutic Implications.
Smetana K; Brábek J
In Vivo; 2020 Jun; 34(3 Suppl):1589-1592. PubMed ID: 32503815
[TBL] [Abstract][Full Text] [Related]
35. COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking.
Magro G
Virus Res; 2020 Sep; 286():198070. PubMed ID: 32569708
[TBL] [Abstract][Full Text] [Related]
36. Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes.
Kastritis E; Kitas GD; Vassilopoulos D; Giannopoulos G; Dimopoulos MA; Sfikakis PP
Rheumatol Int; 2020 Sep; 40(9):1353-1360. PubMed ID: 32654078
[TBL] [Abstract][Full Text] [Related]
37. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
[TBL] [Abstract][Full Text] [Related]
38. The Equitable Distribution of COVID-19 Therapeutics and Vaccines.
Bollyky TJ; Gostin LO; Hamburg MA
JAMA; 2020 Jun; 323(24):2462-2463. PubMed ID: 32379268
[No Abstract] [Full Text] [Related]
39. Should we unstress SARS-CoV-2 infected cells?
Csukasi F; Rico G; Becerra J; Duran I
Cytokine Growth Factor Rev; 2020 Aug; 54():3-5. PubMed ID: 32563554
[No Abstract] [Full Text] [Related]
40. New (re)purpose for an old drug: purinergic modulation may extinguish the COVID-19 thromboinflammatory firestorm.
Kanthi Y; Knight JS; Zuo Y; Pinsky DJ
JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32530438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
